Page results
-
UCLH is reminding staff that gloves are not always required, by reducing the instances where non-sterile plastic gloves are used when treating non-infectious patients. The focus is now on how clean hands are just as effective a barrier against infection.
-
All medications given to you while you are an inpatient are provided free of charge. At follow-up appointments, you may be given a prescription by your doctor or nurse. This must be collected from the hospital pharmacy; you cannot take it to your local chemist. There is a standard prescription charge per item which you can pay for by cash or card.
-
Four women have successfully had combined surgery at UCLH in which they gave birth by caesarean section and at the same time had surgery to reduce their risk of ovarian cancer.
-
Myelodysplastic syndrome (MDS), or myelodysplasia, is a blood disorder that causes a drop in your number of healthy blood cells.
-
This information is for patients who have fibroids. It contains information about what fibroids are, how they can affect you and what treatments are available.
-
Information about the EGA Hospital Charity at UCLH
-
This patient information has been written for patients who are being given post exposure prophylaxis.
-
RAID (Rapid Access Infectious Diseases) clinic is an outpatient service located at the Hospital for Tropical Diseases (address and directions overleaf).
-
Cerebral palsy (CP) is a permanent disorder affecting movement in different parts of the body often accompanied by disturbances of sensation, cognition, communication, perception, behaviour and musculoskeletal problems.
-
Patient information written for patients undergoing a skin snips biopsy.
File results
-
FOI/2024/0440 - Patient reported outcome measures (PROMs) in oncology
-
FOI/2024/0361 - Recording RTT waiting times: Planned patients guidance
-
FOI/2024/0530 - Radiology/ imaging examinations/ patient access to radiology images
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer
-
FOI/2024/0357 - Multiple myeloma treatments
-
FOI/2024/0360 - Radiology Information System (RIS) supplier/ contract/ staff details
-
FOI/2024/0371 - Acute myeloid leukaemia treatment
-
FOI/2024/0376 - Advice provided on topical medication for eczema patients